Science & TechnologySource: The Hindu
A-to-I mRNA Editing and Its Role in Health
Wednesday, 21 May 2025
Read Original ArticleKey Points
A-to-I mRNA Editing is a pivotal biological mechanism where adenosine (A) in mRNA is converted to inosine (I) by ADAR enzymes. This process significantly impacts protein synthesis by altering amino acid sequences, crucial for UPSC aspirants studying GS Paper 3 under Science & Technology. Last Updated: 2025-05-21
Key Facts About A-to-I mRNA Editing
- A-to-I mRNA editing is a process that converts adenosine (A) to inosine (I) in mRNA.
- This editing is performed by ADAR enzymes, which are naturally occurring in the body.
- Inosine is interpreted as guanine (G) during the translation process.
- A-to-I editing can alter the amino acid sequence of proteins, impacting their function.
- Unlike DNA editing, RNA editing leads to temporary changes, allowing for reversible treatments.
- RNA editing is considered safer for repeated treatments due to reduced immune reactions.
- Recent studies highlight its role in the wheat pathogen Fusarium graminearum.
- This process is crucial for correcting mRNA mistakes before protein synthesis.
Significance of A-to-I mRNA Editing in Biotechnology
A-to-I mRNA editing holds macro-level significance in biotechnology, particularly in enhancing agricultural resilience and medical therapies. It aligns with India's strategic goals of advancing scientific research and innovation. The ability to correct mRNA errors without altering the DNA permanently offers a safer alternative for genetic therapies, contributing to India's growth in the global biotechnology sector.
Related Government Schemes/Policies
- Biotechnology Industry Research Assistance Council (BIRAC): Supports innovative biotech research.
- National Biotechnology Development Strategy: Aims to boost India's biotech sector.
UPSC Relevance
- GS Paper 3: Science & Technology - Biotechnology and its applications.
- Prelims Angle: Questions on the function of ADAR enzymes or the process of mRNA editing.
- Mains Angle: Analytical themes on the implications of RNA editing in agriculture and medicine.
- Essay Paper: Topics on the ethical considerations of genetic editing technologies.
FAQ Section
- What is A-to-I mRNA Editing? A-to-I mRNA editing is a biological process where adenosine (A) in mRNA is converted to inosine (I) by ADAR enzymes, impacting protein synthesis.
- Why is A-to-I mRNA Editing important? It allows for the correction of mRNA errors, enabling the production of functional proteins and offering a safer alternative to permanent genetic modifications.
- What are the key features of A-to-I mRNA Editing? Key features include the temporary nature of changes, reduced immune reactions, and its role in correcting mRNA errors before protein synthesis.
Detailed Coverage
- DNA is the genetic material with a double helix structure.
- mRNA is a single-stranded RNA crucial for protein synthesis.
- A-to-I mRNA editing converts adenosine (A) to inosine (I).
- This editing is performed by ADAR enzymes.
- Inosine is read as guanine (G) during translation.
- A-to-I editing alters the amino acid sequence of proteins.
- Transcription creates RNA from DNA, while translation synthesizes proteins.
- RNA editing corrects mRNA mistakes before protein production.
- RNA editing leads to temporary changes, unlike permanent DNA editing.
- It allows for halting therapy if adverse effects occur.
- RNA editing is safer for repeated treatments.
- ADAR enzymes are naturally found in the body, reducing immune reactions.
- Research highlights A-to-I editing in the wheat pathogen Fusarium graminearum.
- This process plays a complex role in biology.
Science & Technology